Literature DB >> 25941107

Comparison of Atrial Fibrillation Guidelines.

Thure Filskov Overvad1, Peter Brønnum Nielsen1, Torben Bjerregaard Larsen2,3.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25941107      PMCID： PMC4579202          DOI： 10.1007/s11606-015-3379-2

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  5 in total

1.  Clinical Benefit of American College of Chest Physicians versus European Society of Cardiology Guidelines for Stroke Prophylaxis in Atrial Fibrillation.

Authors:  Ambar A Andrade; Juan Li; Martha J Radford; David S Nilasena; Brian F Gage
Journal:  J Gen Intern Med       Date:  2015-02-10       Impact factor: 5.128

2.  Net clinical benefit of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus no treatment in a 'real world' atrial fibrillation population: a modelling analysis based on a nationwide cohort study.

Authors:  Amitava Banerjee; Deirdre A Lane; Christian Torp-Pedersen; Gregory Y H Lip
Journal:  Thromb Haemost       Date:  2011-12-21       Impact factor: 5.249

3.  Moving the tipping point: the decision to anticoagulate patients with atrial fibrillation.

Authors:  Mark H Eckman; Daniel E Singer; Jonathan Rosand; Steven M Greenberg
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2010-12-07

4.  Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.

Authors:  Greg C Flaker; Michael Gruber; Stuart J Connolly; Steven Goldman; Sandra Chaparro; Alec Vahanian; Matti O Halinen; Jay Horrow; Jonathan L Halperin
Journal:  Am Heart J       Date:  2006-11       Impact factor: 4.749

Review 5.  Vitamin K antagonists in heart disease: current status and perspectives (Section III). Position paper of the ESC Working Group on Thrombosis--Task Force on Anticoagulants in Heart Disease.

Authors:  Raffaele De Caterina; Steen Husted; Lars Wallentin; Felicita Andreotti; Harald Arnesen; Fedor Bachmann; Colin Baigent; Kurt Huber; Jørgen Jespersen; Steen Dalby Kristensen; Gregory Y H Lip; João Morais; Lars Hvilsted Rasmussen; Agneta Siegbahn; Freek W A Verheugt; Jeffrey I Weitz
Journal:  Thromb Haemost       Date:  2013-11-14       Impact factor: 5.249
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.